Impaired systemic angiogenesis in pulmonary arterial hypertension

肺动脉高压时全身血管生成受损

• 批准号: 305728
• 负责人: Provencher Steeve
• 金额: $ 32.7万
• 依托单位: Institut universitaire de cardiologie et de pneumologie de Qubec - U Laval
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-03-01 至 2018-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=305728&lang=en
• 关键词: Angiogenesis; Exercise Pathophysiology; Micrornas; Pulmonary Arterial Hypertension; Skeletal Muscle

Pulmonary arterial hypertension (PAH) is characterized by the progressive increase in pulmonary artery pressure and right heart failure. PAH predominantly affects young people between 20-60 years of age. Recent studies the importance of loss of the vascul

肺动脉高压（PAH）的特征是肺动脉压进行性升高和右心衰竭。PAH主要影响20-60岁的年轻人。最近的研究表明，